rss
J Clin Pathol 2006;59:867-869 doi:10.1136/jcp.2005.034876
  • Original article

Adjusting copper concentrations for caeruloplasmin levels in routine clinical practice

  1. P J Twomey1,
  2. A Viljoen2,
  3. I M House3,
  4. T M Reynolds4,
  5. A S Wierzbicki5
  1. 1Department of Clinical Biochemistry, Ipswich Hospital, Ipswich, UK
  2. 2Department of Chemical Pathology, Addenbrooke’s Hospital, Cambridge, UK
  3. 3The Medical Toxicology Unit Laboratory, Guy’s and St Thomas’ Hospital Trust, London, UK
  4. 4Department of Chemical Pathology, Queen’s Hospital, Burton on Trent, UK
  5. 5Department of Chemical Pathology, St Thomas’ Hospital, London
  1. Correspondence to:
 P J Twomey
 Ipswich Hospital, Heath Road, Ipswich IP4 5PD, UK; patrick.twomey{at}ipswichhospital.nhs.uk
  • Accepted 20 February 2006
  • Published Online First 27 April 2006

Abstract

Background: An investigation on copper metabolism usually includes the measurement of serum levels of copper and caeruloplasmin. Using these levels, some laboratories derive levels of non-caeruloplasmin-bound copper (NCC); however, a considerable number of patients may show negative values, which is not physiologically possible.

Aim: To derive an equation for adjusted copper in a manner similar to that widely accepted for adjusted calcium.

Methods: A linear regression equation for the relationship between caeruloplasmin and copper was used: [copper] (μmol/l) = 0.052×[caeruloplasmin] (mg/l). An equation for copper adjusted for caeruloplasmin was derived using this equation and the reference interval of 10–25 μmol/l for copper.

Results: The derived equation was [adjusted copper] (μmol/l) = [total copper] (μmol/l)+0.052×[caeruloplasmin] (mg/l)+17.5 (μmol/l). The adjusted copper concentrations on the 2.5th and 97.5th centiles were 12.7 and 21.5 μmol/l, respectively, with the population having a gaussian distribution. The relationship between NCC and the adjusted copper concentrations is linear and independent of caeruloplasmin concentration.

Conclusion: Calculation of copper adjusted for caeruloplasmin uses the same variables as those for NCC. Accordingly, the problems that are caused by the lack of specificity of caeruloplasmin immunoassays are the same as those identified for NCC. This calculation, however, overcomes the negative values that are found in a considerable minority of patients with NCC, as well as age and sex differences in the caeruloplasmin reference interval. As the concept is already familiar to non-laboratory healthcare professionals in the form of calcium adjusted for albumin, this method is potentially less confusing than that for NCC.

Footnotes

  • Published Online First 27 April 2006

  • Competing interests: None declared.

Register for free content


Free trial
Individuals may register for a free 60 day online trial to all content.

Free archive
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they ar